Second-generation Src/Abl inhibitor bosutinib effectively induces apoptosis in human esophageal squamous cell carcinoma (ESCC) cells via inhibiting Src/Abl signaling. [electronic resource]
Producer: 20200313Description: 54-60 p. digitalISSN:- 0028-2685
- Aniline Compounds -- pharmacology
- Apoptosis
- Cell Line, Tumor
- Cell Proliferation
- Esophageal Neoplasms -- drug therapy
- Esophageal Squamous Cell Carcinoma -- drug therapy
- Humans
- Nitriles -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-abl -- antagonists & inhibitors
- Proto-Oncogene Proteins pp60(c-src) -- antagonists & inhibitors
- Quinolines -- pharmacology
- Signal Transduction
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.